Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis.

Muthukrishnan G, Masters EA, Daiss JL, Schwarz EM.

Curr Osteoporos Rep. 2019 Nov 13. doi: 10.1007/s11914-019-00548-4. [Epub ahead of print] Review.

PMID:
31721069
2.

Transgender Adolescents' Uses of Social Media for Social Support.

Selkie E, Adkins V, Masters E, Bajpai A, Shumer D.

J Adolesc Health. 2019 Nov 2. pii: S1054-139X(19)30421-5. doi: 10.1016/j.jadohealth.2019.08.011. [Epub ahead of print]

PMID:
31690534
3.

Evolving concepts in bone infection: redefining "biofilm", "acute vs. chronic osteomyelitis", "the immune proteome" and "local antibiotic therapy".

Masters EA, Trombetta RP, de Mesy Bentley KL, Boyce BF, Gill AL, Gill SR, Nishitani K, Ishikawa M, Morita Y, Ito H, Bello-Irizarry SN, Ninomiya M, Brodell JD Jr, Lee CC, Hao SP, Oh I, Xie C, Awad HA, Daiss JL, Owen JR, Kates SL, Schwarz EM, Muthukrishnan G.

Bone Res. 2019 Jul 15;7:20. doi: 10.1038/s41413-019-0061-z. eCollection 2019. Review.

4.

Role of the Advanced Nurse Practitioner Within Teenage and Young Adult Oncology. What is the Impact on Patient and Staff Experience of a New Nurse Practitioner Role to a Teenage and Young Adult Service?

Masters E, Weston C, Chisholm J, Soanes L.

J Adolesc Young Adult Oncol. 2019 Aug 28. doi: 10.1089/jayao.2019.0020. [Epub ahead of print]

PMID:
31460812
5.

Vitellaria paradoxa nutshells from seven sub-Saharan countries as potential herbal medicines for treating diabetes based on chemical compositions, HPLC fingerprints and bioactivity evaluation.

Li D, Xiao JQ, Liu WY, Zhang CF, Akihisa T, Abe M, Masters ET, Zhai WW, Feng F, Zhang J.

Chin J Nat Med. 2019 Jun;17(6):446-460. doi: 10.1016/S1875-5364(19)30052-4.

PMID:
31262457
6.

An in vitro platform for elucidating the molecular genetics of S. aureus invasion of the osteocyte lacuno-canalicular network during chronic osteomyelitis.

Masters EA, Salminen AT, Begolo S, Luke EN, Barrett SC, Overby CT, Gill AL, de Mesy Bentley KL, Awad HA, Gill SR, Schwarz EM, McGrath JL.

Nanomedicine. 2019 Oct;21:102039. doi: 10.1016/j.nano.2019.102039. Epub 2019 Jun 24.

PMID:
31247310
7.

A comprehensive search of functional sequence space using large mammalian display libraries created by gene editing.

Parthiban K, Perera RL, Sattar M, Huang Y, Mayle S, Masters E, Griffiths D, Surade S, Leah R, Dyson MR, McCafferty J.

MAbs. 2019 Jul;11(5):884-898. doi: 10.1080/19420862.2019.1618673. Epub 2019 Jun 9.

8.

Return to Normal Activity after Colonoscopy Using Propofol Sedation.

Hayakawa E, Barger J, Main W, Masters E, Pershing M, Patil N, Kerner B.

Am Surg. 2019 Apr 1;85(4):434-437. No abstract available.

PMID:
31043207
9.

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer.

Barrows SM, Wright K, Copley-Merriman C, Kaye JA, Chioda M, Wiltshire R, Torgersen KM, Masters ET.

Lung Cancer (Auckl). 2019 Feb 8;10:11-20. doi: 10.2147/LCTT.S179349. eCollection 2019. Review.

10.

Natural Language Processing-Identified Problem Opioid Use and Its Associated Health Care Costs.

Masters ET, Ramaprasan A, Mardekian J, Palmer RE, Gross DE, Cronkite D, Von Korff M, Carrell DS.

J Pain Palliat Care Pharmacother. 2018 Jun - Sep;32(2-3):106-115. doi: 10.1080/15360288.2018.1488794. Epub 2019 Jan 31.

PMID:
30702378
11.

Streamlined SMFA and mosquito dark-feeding regime significantly improve malaria transmission-blocking assay robustness and sensitivity.

Habtewold T, Tapanelli S, Masters EKG, Hoermann A, Windbichler N, Christophides GK.

Malar J. 2019 Jan 25;18(1):24. doi: 10.1186/s12936-019-2663-8.

12.

Publisher Correction: In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.

Laustsen AH, Karatt-Vellatt A, Masters EW, Arias AS, Pus U, Knudsen C, Oscoz S, Slavny P, Griffiths DT, Luther AM, Leah RA, Lindholm M, Lomonte B, Gutiérrez JM, McCafferty J.

Nat Commun. 2018 Nov 20;9(1):4957. doi: 10.1038/s41467-018-07480-8.

13.

In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.

Laustsen AH, Karatt-Vellatt A, Masters EW, Arias AS, Pus U, Knudsen C, Oscoz S, Slavny P, Griffiths DT, Luther AM, Leah RA, Lindholm M, Lomonte B, Gutiérrez JM, McCafferty J.

Nat Commun. 2018 Oct 2;9(1):3928. doi: 10.1038/s41467-018-06086-4. Erratum in: Nat Commun. 2018 Nov 20;9(1):4957.

14.

Cost of opioid medication abuse with and without tampering in the USA.

Vietri J, Masters ET, Barsdorf AI, Mardekian J.

Clinicoecon Outcomes Res. 2018 Aug 10;10:433-442. doi: 10.2147/CEOR.S168145. eCollection 2018.

15.

Staphylococcus aureus Evasion of Host Immunity in the Setting of Prosthetic Joint Infection: Biofilm and Beyond.

Ricciardi BF, Muthukrishnan G, Masters E, Ninomiya M, Lee CC, Schwarz EM.

Curr Rev Musculoskelet Med. 2018 Sep;11(3):389-400. doi: 10.1007/s12178-018-9501-4. Review.

16.

Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer.

Wu YL, Lu S, Lu Y, Zhou J, Shi YK, Sriuranpong V, Ho JCM, Ong CK, Tsai CM, Chung CH, Wilner KD, Tang Y, Masters ET, Selaru P, Mok TS.

J Thorac Oncol. 2018 Oct;13(10):1539-1548. doi: 10.1016/j.jtho.2018.06.012. Epub 2018 Aug 14.

17.

Real-World Use and Outcomes of ALK-Positive Crizotinib-Treated Metastatic NSCLC in US Community Oncology Practices: A Retrospective Observational Study.

Reynolds C, Masters ET, Black-Shinn J, Boyd M, Mardekian J, Espirito JL, Chioda M.

J Clin Med. 2018 May 29;7(6). pii: E129. doi: 10.3390/jcm7060129.

18.

Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib.

Davis KL, Kaye JA, Masters ET, Iyer S.

Curr Oncol. 2018 Feb;25(1):e40-e49. doi: 10.3747/co.25.3723. Epub 2018 Feb 28.

19.

Educational intervention for physicians to address the risk of opioid abuse.

Pasquale MK, Sheer RL, Mardekian J, Masters ET, Patel NC, Hurwitch AR, Weber JJ, Jorga A, Roland CL.

J Opioid Manag. 2017 Sep/Oct;13(5):303-313. doi: 10.5055/jom.2017.0399.

PMID:
29199396
20.

Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain.

Weil AJ, Masters ET, Barsdorf AI, Bass A, Pixton G, Wilson JG, Wolfram G.

Health Qual Life Outcomes. 2017 Oct 17;15(1):202. doi: 10.1186/s12955-017-0749-y.

21.

A systematic review of the effectiveness of policies restricting access to pregabalin.

Stacey BR, Liss J, Behar R, Sadosky A, Parsons B, Masters ET, Hlavacek P.

BMC Health Serv Res. 2017 Aug 25;17(1):600. doi: 10.1186/s12913-017-2503-x. Review.

22.

Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration.

Green JL, Bucher Bartelson B, Le Lait MC, Roland CL, Masters ET, Mardekian J, Bailey JE, Dart RC.

Drug Alcohol Depend. 2017 Jun 1;175:140-145. doi: 10.1016/j.drugalcdep.2017.01.039. Epub 2017 Mar 28.

23.

Fibromyalgia Outcomes Over Time: Results from a Prospective Observational Study in the United States.

Schaefer CP, Adams EH, Udall M, Masters ET, Mann RM, Daniel SR, McElroy HJ, Cappelleri JC, Clair AG, Hopps M, Staud R, Mease P, Silverman SL.

Open Rheumatol J. 2016 Nov 30;10:109-121. doi: 10.2174/1874312901610010109. eCollection 2016.

24.

Enhancing Risk Assessment in Patients Receiving Chronic Opioid Analgesic Therapy Using Natural Language Processing.

Haller IV, Renier CM, Juusola M, Hitz P, Steffen W, Asmus MJ, Craig T, Mardekian J, Masters ET, Elliott TE.

Pain Med. 2017 Oct 1;18(10):1952-1960. doi: 10.1093/pm/pnw283.

PMID:
28034982
25.

Evaluating increased resource use in fibromyalgia using electronic health records.

Margolis JM, Masters ET, Cappelleri JC, Smith DM, Faulkner S.

Clinicoecon Outcomes Res. 2016 Nov 16;8:675-683. eCollection 2016.

26.

Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability.

Johnston SS, Alexander AH, Masters ET, Mardekian J, Semel D, Malangone-Monaco E, Riehle E, Wilson K, Sadosky A.

J Occup Environ Med. 2016 Nov;58(11):1087-1097.

PMID:
27820758
27.

Rosette-Disrupting Effect of an Anti-Plasmodial Compound for the Potential Treatment of Plasmodium falciparum Malaria Complications.

Ch'ng JH, Moll K, Quintana Mdel P, Chan SC, Masters E, Moles E, Liu J, Eriksson AB, Wahlgren M.

Sci Rep. 2016 Jul 11;6:29317. doi: 10.1038/srep29317.

28.

Progression of fibromyalgia: results from a 2-year observational fibromyalgia and chronic pain study in the US.

Adams EH, McElroy HJ, Udall M, Masters ET, Mann RM, Schaefer CP, Cappelleri JC, Clair AG, Hopps M, Daniel SR, Mease P, Silverman SL, Staud R.

J Pain Res. 2016 Jun 1;9:325-36. doi: 10.2147/JPR.S100043. eCollection 2016.

29.

Burden of illness in fibromyalgia patients with comorbid depression.

Bateman L, Sarzi-Puttini P, Burbridge CL, Landen JW, Masters ET, Bhadra Brown P, Scavone JM, Emir B, Vissing RS, Clair AG, Pauer LR.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S106-13. Epub 2016 Mar 10.

PMID:
27057659
30.

Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review.

Oderda GM, Lake J, Rüdell K, Roland CL, Masters ET.

J Pain Palliat Care Pharmacother. 2015;29(4):388-400. doi: 10.3109/15360288.2015.1101641. Review.

PMID:
26654413
31.

Using natural language processing to identify problem usage of prescription opioids.

Carrell DS, Cronkite D, Palmer RE, Saunders K, Gross DE, Masters ET, Hylan TR, Von Korff M.

Int J Med Inform. 2015 Dec;84(12):1057-64. doi: 10.1016/j.ijmedinf.2015.09.002. Epub 2015 Sep 25.

PMID:
26456569
32.

Evaluating Guideline-recommended Pain Medication Use Among Patients with Newly Diagnosed Fibromyalgia.

Halpern R, Shah SN, Cappelleri JC, Masters ET, Clair A.

Pain Pract. 2016 Nov;16(8):1027-1039. doi: 10.1111/papr.12364. Epub 2015 Oct 7.

PMID:
26443495
33.

Identification of a potential fibromyalgia diagnosis using random forest modeling applied to electronic medical records.

Emir B, Masters ET, Mardekian J, Clair A, Kuhn M, Silverman SL.

J Pain Res. 2015 Jun 10;8:277-88. doi: 10.2147/JPR.S8256. eCollection 2015.

34.

The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States.

Schaefer C, Mann R, Masters ET, Cappelleri JC, Daniel SR, Zlateva G, McElroy HJ, Chandran AB, Adams EH, Assaf AR, McNett M, Mease P, Silverman S, Staud R.

Pain Pract. 2016 Jun;16(5):565-79. doi: 10.1111/papr.12302. Epub 2015 May 16.

PMID:
25980433
35.

Melanogenesis-inhibitory activity and cancer chemopreventive effect of glucosylcucurbic acid from shea (Vitellaria paradoxa) kernels.

Zhang J, Kurita M, Ebina K, Ukiya M, Tokuda H, Yasukawa K, Masters ET, Shimizu N, Akihisa M, Feng F, Akihisa T.

Chem Biodivers. 2015 Apr;12(4):547-58. doi: 10.1002/cbdv.201400424.

PMID:
25879500
36.

Electronic medical record data to identify variables associated with a fibromyalgia diagnosis: importance of health care resource utilization.

Masters ET, Mardekian J, Emir B, Clair A, Kuhn M, Silverman SL.

J Pain Res. 2015 Mar 5;8:131-8. doi: 10.2147/JPR.S74900. eCollection 2015.

37.

The prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notes.

Palmer RE, Carrell DS, Cronkite D, Saunders K, Gross DE, Masters E, Donevan S, Hylan TR, Von Kroff M.

Pain. 2015 Jul;156(7):1208-14. doi: 10.1097/j.pain.0000000000000145.

PMID:
25760471
38.

Automated prediction of risk for problem opioid use in a primary care setting.

Hylan TR, Von Korff M, Saunders K, Masters E, Palmer RE, Carrell D, Cronkite D, Mardekian J, Gross D.

J Pain. 2015 Apr;16(4):380-7. doi: 10.1016/j.jpain.2015.01.011. Epub 2015 Jan 29.

PMID:
25640294
39.

Triterpene glycosides and other polar constituents of shea (Vitellaria paradoxa) kernels and their bioactivities.

Zhang J, Kurita M, Shinozaki T, Ukiya M, Yasukawa K, Shimizu N, Tokuda H, Masters ET, Akihisa M, Akihisa T.

Phytochemistry. 2014 Dec;108:157-70. doi: 10.1016/j.phytochem.2014.09.017. Epub 2014 Oct 21.

PMID:
25446237
40.

Prior authorization in the treatment of patients with pDPN and FM.

Placzek HE, Masters ET, Gu T, Cappelleri JC, Wasser TE, Clair AG, Cook JP, Eisenberg DF.

Pain Pract. 2015 Jan;15(1):E9-19. doi: 10.1111/papr.12258. Epub 2014 Nov 11.

PMID:
25387598
41.

Interpreting effect sizes and clinical relevance of pharmacological interventions for fibromyalgia.

Arnold LM, Cappelleri JC, Clair A, Masters ET.

Pain Ther. 2013 Jun;2(1):65-71. doi: 10.1007/s40122-013-0011-1. Epub 2013 Apr 18.

42.

Triacylglycerol and triterpene ester composition of shea nuts from seven African countries.

Akihisa T, Kojima N, Katoh N, Kikuchi T, Fukatsu M, Shimizu N, Masters ET.

J Oleo Sci. 2011;60(8):385-91.

43.

Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin.

Capodagli GC, McKercher MA, Baker EA, Masters EM, Brunzelle JS, Pegan SD.

J Virol. 2011 Apr;85(7):3621-30. doi: 10.1128/JVI.02496-10. Epub 2011 Jan 12.

44.

Triterpene alcohol and fatty acid composition of shea nuts from seven African countries.

Akihisa T, Kojima N, Katoh N, Ichimura Y, Suzuki H, Fukatsu M, Maranz S, Masters ET.

J Oleo Sci. 2010;59(7):351-60.

45.

Ehrlichia ewingii in an immunocompetent adult.

Masters EJ, Storch GA, Sumner JW.

Mo Med. 2009 Jul-Aug;106(4):301-3.

PMID:
19753925
46.

Early treatment of tick borne illnesses.

Masters EJ.

Mo Med. 2009 Jul-Aug;106(4):250-2. No abstract available.

PMID:
19753912
47.

Preliminary serologic investigation of 'Rickettsia amblyommii' in the aetiology of Southern tick associated rash illness (STARI).

Nicholson WL, Masters E, Wormser GP.

Clin Microbiol Infect. 2009 Dec;15 Suppl 2:235-6. doi: 10.1111/j.1469-0691.2008.02155.x. Epub 2009 May 18. No abstract available.

48.

Estimating individual-level exposure to airborne polycyclic aromatic hydrocarbons throughout the gestational period based on personal, indoor, and outdoor monitoring.

Choi H, Perera F, Pac A, Wang L, Flak E, Mroz E, Jacek R, Chai-Onn T, Jedrychowski W, Masters E, Camann D, Spengler J.

Environ Health Perspect. 2008 Nov;116(11):1509-18. doi: 10.1289/ehp.10972. Epub 2008 Jul 16.

49.

A clinical observation: loxoscelism pain managed with lidocaine patch.

Masters EJ.

South Med J. 2008 May;101(5):565-6. doi: 10.1097/SMJ.0b013e31816c00d3. No abstract available.

PMID:
18458633
50.

STARI, or Masters disease: Lone Star tick-vectored Lyme-like illness.

Masters EJ, Grigery CN, Masters RW.

Infect Dis Clin North Am. 2008 Jun;22(2):361-76, viii. doi: 10.1016/j.idc.2007.12.010. Review.

PMID:
18452807

Supplemental Content

Loading ...
Support Center